Cargando…
Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
BACKGROUND: The use of tacrolimus (TAC) in patients after heart transplantation (HTX) has increased over the last few years. AIM: In this retrospective study, we evaluated the effects of a TAC (conventional and extended-release TAC)-based immunosuppressive therapy regarding rejection profile in comp...
Autores principales: | Helmschrott, Matthias, Beckendorf, Jan, Akyol, Ceylan, Ruhparwar, Arjang, Schmack, Bastian, Erbel, Christian, Gleissner, Christian A, Akhavanpoor, Mohammadreza, Ehlermann, Philipp, Bruckner, Tom, Katus, Hugo A, Doesch, Andreas O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166906/ https://www.ncbi.nlm.nih.gov/pubmed/25246772 http://dx.doi.org/10.2147/DDDT.S68542 |
Ejemplares similares
-
Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation
por: Helmschrott, Matthias, et al.
Publicado: (2015) -
Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy
por: Rivinius, Rasmus, et al.
Publicado: (2014) -
Conversion to generic cyclosporine A in stable chronic patients after heart transplantation
por: Kraeuter, Maximilian, et al.
Publicado: (2013) -
Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2016) -
Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
por: Doesch, Andreas O, et al.
Publicado: (2013)